Pacira BioSciences (NASDAQ:PCRX) Price Target Cut to $30.00 by Analysts at Needham & Company LLC
Pacira BioSciences (NASDAQ:PCRX – Free Report) had its price objective cut by Needham & Company LLC from $32.00 to $30.00 in a report issued on Friday,Benzinga reports. They currently have a buy rating on the stock. Several other brokerages also recently commented on PCRX. HC Wainwright upped their price objective on shares of Pacira BioSciences […]
More Stories
Wexford Capital LP Buys New Shares in NVIDIA Co. (NASDAQ:NVDA)
Wexford Capital LP bought a new position in shares of NVIDIA Co. (NASDAQ:NVDA – Free Report) during the 4th quarter,...
Best Streaming Stocks To Keep An Eye On – May 30th
NVIDIA, AppLovin, Spotify Technology, Live Nation Entertainment, and Walt Disney are the five Streaming stocks to watch today, according to...
Infrastructure Stocks Worth Watching – May 30th
NVIDIA, Alphabet, and Broadcom are the three Infrastructure stocks to watch today, according to MarketBeat’s stock screener tool. Infrastructure stocks...
Two Sigma Investments LP Cuts Position in Academy Sports and Outdoors, Inc. (NASDAQ:ASO)
Two Sigma Investments LP reduced its holdings in shares of Academy Sports and Outdoors, Inc. (NASDAQ:ASO – Free Report) by...
Two Sigma Advisers LP Has $974.62 Million Position in Amazon.com, Inc. (NASDAQ:AMZN)
Two Sigma Advisers LP boosted its holdings in Amazon.com, Inc. (NASDAQ:AMZN – Free Report) by 121.7% in the 4th quarter,...
GTS Securities LLC Invests $204,000 in Fortune Brands Innovations, Inc. (NYSE:FBIN)
GTS Securities LLC acquired a new position in shares of Fortune Brands Innovations, Inc. (NYSE:FBIN – Free Report) in the...